of the transaction The Company will purchase ordinary shares of Aesthetic Zecret (At-Ze), including current ex-shareholders holding in the amount of 500,000 shares or 100 percent of paid-up registered
or 100 percent of paid-up registered capital plus newly ordinary shares in the amount of 300,000 shares, so the totaling amount of shares is 800,000 shares or 100 percent of paid up registered capital
% of paid up capital, Total investment 50 Millions baht. The acquisition of BS Myco Biotech shares will result in the BS Myco Biotech being a subsidiary of the Company. The Company signed the share
period, the offerees tender CSL’s shares less than or equal to 50 percent of the total issued shares of CSL, or less than 297,257,385 shares, according to the number of issued and paid-up shares of CSL as
- Total liabilities 79,092 Minority interest - Net tangible assets 70,675 Registered and paid up capital 18,084 Net profit (latest 12 months) 56,013 Financial Information Consolidate Financial Statement
Relationship : The major shareholder of the Company (J.S.P.) and hold 1,054,791,300 Shares, equivalent to 25.11% of the paid-up of the company (Including related and close relatives) (At as September 30, 2018
Relationship : The major shareholder of the Company (J.S.P.) and hold 1,054,791,300 Shares, equivalent to 25.11% of the paid-up of the company (Including related and close relatives) (At as September 30, 2018
par value of 10.00 Baht. The total value 130,000,000 Baht, paid – up as 101,625,000 Baht. Separate into 100,000 ordinary shares has fully - paid of 10 Baht per share, totally in 1,000,000 Baht
) from the current ex-shareholders holding in the amount of 500,000 shares; a par value of THB 100 per share or 100 percent of paid-up registered capital plus newly ordinary shares in the amount of 300,000
per share of up to Baht 10 total purchase price of up to Baht 1,000,000. 2. Subscription of newly issued shares of Anypay under which there will be the increase in the registered capital of Anypay from